Machry Rafael Vaz, Pedroso Henrique Umpierre, Vasconcellos Luthiele Silva, Nunes Rafaela Ramos, Evaldt Cibelle de Abreu, Yunes Filho Eduardo Bardou, Rodrigues Ticiana da Costa
Departamento de Medicina Interna, Faculdade de Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brasil.
Rev Saude Publica. 2018;52:60. doi: 10.11606/s1518-8787.2018052000144. Epub 2018 May 17.
To evaluate if the closer follow-up with the supply of insulin pens and the measurement of capillary blood glucose improve the management of older patients with type 2 diabetes without adequate glycemic control despite extensive therapy.
This is a prospective, non-randomized, quasi-experimental study. We have included 45 patients over 60 years old, from both sexes, with glycated hemoglobin (HbA1c) > 8.5% using oral hypoglycemic agents and insulin. The intervention consisted of monthly medical visits, with the provision of insulin pens and strips for blood glucose measurement. All patients received insulin pen, refills of Neutral Protamine Hagedorn and regular insulin, needles for the pen, blood glucose meter, and capillary blood glucose tests (three tests/day). Treatment was adjusted with the same endocrinologist monthly for six months. Glycated hemoglobin was measured at baseline and 12 and 24 weeks after intervention.
Glycated hemoglobin at baseline was 10.34% (SE = 0.22%) and 8.54% (SE = 0.24%, p < 0.001) and 8.09% (SE = 0.21%, p < 0.001) at 12 and 24 weeks after intervention, respectively, with a significant reduction from baseline.
More frequent medical visits, with treatment inputs including the use of insulin pens and self-monitoring, have improved glycemic control (reduction of 2.25% in HbA1C, on average, at 24 weeks of follow-up). Our data support a change in the management and medical behavior of older patients with chronically decompensated diabetes.
评估胰岛素笔供应及毛细血管血糖测量的更密切随访,是否能改善尽管接受广泛治疗但血糖控制仍不佳的老年2型糖尿病患者的管理。
这是一项前瞻性、非随机、准实验研究。我们纳入了45名60岁以上的患者,男女均有,使用口服降糖药和胰岛素,糖化血红蛋白(HbA1c)>8.5%。干预措施包括每月一次门诊,提供胰岛素笔和血糖测量试纸。所有患者均接受胰岛素笔、中效胰岛素和正规胰岛素补充剂、笔用针头、血糖仪以及毛细血管血糖检测(每天三次检测)。由同一位内分泌科医生每月调整治疗方案,持续六个月。在基线时以及干预后12周和24周测量糖化血红蛋白。
基线时糖化血红蛋白为10.34%(标准误=0.22%),干预后12周和24周分别为8.54%(标准误=0.24%,p<0.001)和8.09%(标准误=0.21%,p<0.001),与基线相比有显著降低。
更频繁的门诊就诊,包括使用胰岛素笔和自我监测等治疗措施,改善了血糖控制(随访24周时,HbA1C平均降低2.25%)。我们的数据支持改变慢性失代偿性糖尿病老年患者的管理和医疗行为。